BioLife Sciences Inc.
BLFE
$0.00
$0.000.00%
OTC PK
| 02/28/2022 | 02/28/2021 | ||||
|---|---|---|---|---|---|
| Net Income | -132.00K | -67.40K | |||
| Total Depreciation and Amortization | -- | -- | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 49.80K | 27.10K | |||
| Change in Net Operating Assets | 80.20K | -5.60K | |||
| Cash from Operations | -2.00K | -45.90K | |||
| Capital Expenditure | -- | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -- | -- | |||
| Total Debt Issued | -- | 75.00K | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | -- | 75.00K | |||
| Foreign Exchange rate Adjustments | 500.00 | 12.00K | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -1.50K | 41.10K | |||